Oral KT-621 study for healthy volunteers
This trial tests a new oral medication, KT-621, given as different tablet or capsule forms. It helps researchers understand how the body handles the drug, which is the first step toward future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult of any gender.
- Weigh at least 110 pounds if you're a man or 88 pounds if you're a woman.
- Have a body mass index (BMI) between 18 and 32.
- Be generally healthy with no major medical conditions like heart, lung, kidney, or stomach disease.
- Not have taken any other experimental drug or device in the last 30 days (or 5 half-lives, whichever is longer).
- Agree to use effective contraception and, if you're a man, not donate sperm during the study and for 90 days after the last dose.
- If you're a woman, you cannot be pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
This study tests a new medicine called KS101 to see if it is safe and how it works in healthy people for the first time. It is a first-in-human trial, meaning this is the first time the drug is given to people, and your health will be closely monitored throughout.
This trial is for people with asthma who already completed a previous study of the drug KT-621. It aims to see if taking KT-621 for a longer time is safe and helpful.
This study tests a new medicine called KHN702 in healthy volunteers to see how the body processes it and whether it is safe. It is an early-stage trial, so participants will help find out how the drug works before it is studied in patients.
This early-phase trial tests the safety of KMY tablets in healthy adults. It helps determine how well the drug is tolerated and how it moves through the body.
This trial is testing a new medicine called KHN707 in healthy people. The goal is to see if it is safe and how the body handles it. It is an early-stage study, so it is not intended to treat any condition yet.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.